Psychosocial Outcomes in Online Cancer Support Groups
1 other identifier
interventional
51
1 country
1
Brief Summary
Purpose: The purpose of this project is to evaluate whether psychosocial outcomes in women with breast cancer differ based on the format of online group support. This objective will be addressed by the following specific aims:
- 1.Specific Aim #1 is to determine if there is a difference in depressive symptoms between women with breast cancer assigned to one of two treatment conditions: moderated online support or peer-led online support.
- 2.H1: Women with breast cancer who participate in moderated online support will report fewer depressive symptoms than women with breast cancer in peer led online support.
- 3.Specific Aim #2 is to determine if there is a difference in perceived social support between women with breast cancer who are assigned to one of two treatment conditions: moderated online support or peer-led online support.
- 4.H2: Women with breast cancer who participate in moderated online support will report greater perceived social support than women with breast cancer in peer-led online support.
- 5.Specific Aim #3 is to determine if there is a difference in quality of life in women with breast cancer who are assigned to one of two treatment conditions: moderated online support or peer-led online support.
- 6.H3: Women with breast cancer who participate in moderated online support will report better quality of life than women with breast cancer in peer-led online support. NOTE: Once the study began, it was obvious that we could not prevent anyone from joining a support group, if that was her choice. We also could not control if participants joined a second online support group or face-to-face group during the study. Therefore, we decided to omit a "usual care" (no support) group. The study was completed with just two groups: moderated and peer-support.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable breast-cancer
Started Sep 2006
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2006
CompletedFirst Submitted
Initial submission to the registry
September 28, 2006
CompletedFirst Posted
Study publicly available on registry
October 2, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2009
CompletedResults Posted
Study results publicly available
December 21, 2010
CompletedDecember 21, 2010
November 1, 2010
2.8 years
September 28, 2006
September 29, 2010
November 23, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Scores on the Personal Resource Questionnaire 85.
The Personal Resource Questionnaire 85 (PRQ85), Part II measures perceived social support and consists of 25 items in a seven-point Likert format which are rated from seven (7) strongly agree, to one (1) strongly disagree. Scores range from 25 to 175 with higher scores indicative of higher levels of perceived social support. Alpha reliability of the PRQ 85 has been demonstrated at \>.90
16 weeks
Scores on the CES-D Scale
The Center for Epidemiologic Studies Depression Scale (CES-D) is a 20-item self-report scale widely used in the assessment of depression. Each item is given a rating of 0 to 3, with a potential range of 0 to 60 for the entire scale. Higher scores are associated with depression. The cutoff for the diagnosis of Major Depressive Disorder on the CES-D is 16. The instrument is a reliable measure (Alpha \>.85) of depression
16 weeks
Scores on the Quality of Life (QOL) Question on the Rotterdam Symptom Check List (RSCL).
The Rotterdam Symptom Checklist (RSCL) measures quality of life in cancer patients. The RSCL checklist includes a QOL life question on a scale of 1 (excellent) to 7 (extremely poor). This was used as a measure of overall QOL.
16 weeks
Study Arms (2)
moderated online support
EXPERIMENTAL12-week online support led by a healthcare professional
peer-led support
EXPERIMENTAL12-week online support group in a peer-led format
Interventions
one 12-week online support group led by a professional healthcare provider
Eligibility Criteria
You may qualify if:
- Female
- At least 21 years of age
- Internet access; Able to read and write English
- Have completed treatment for breast cancer in the past 36 months or are receiving treatment
- Do not currently belong to an online or face-to-face cancer support group
- Internet access
You may not qualify if:
- Male
- not diagnosed with breast cancer
- under 21 years of age
- received treatment more than 36 months ago for breast cancer
- no Internet access
- unable to read and write English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Delaware
Newark, Delaware, 19716, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
One limitation was the lack of a control group of women who did not take part in an online or face-to-face support group. The reasons for this are explained above.
Results Point of Contact
- Title
- Paula Klemm, PhD, RN, OCN
- Organization
- University of Delaware
Study Officials
- PRINCIPAL INVESTIGATOR
Paula Klemm, PhD
University of Delaware School of Nursing
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 28, 2006
First Posted
October 2, 2006
Study Start
September 1, 2006
Primary Completion
July 1, 2009
Study Completion
July 1, 2009
Last Updated
December 21, 2010
Results First Posted
December 21, 2010
Record last verified: 2010-11